Louise Wang Zhiying Humphrey

Array ( [id] => 9073908 [patent_doc_number] => 08551484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Human antibodies against hepatitis C virus (HCV) and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/527663 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28477 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606744 [patent_doc_number] => 20100099078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'METHOD FOR DESIGNING A DRUG REGIME FOR HIV-INFECTED PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/524120 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12461 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099078.pdf [firstpage_image] =>[orig_patent_app_number] => 12524120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601564 [patent_doc_number] => 20100048879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'MULTIMERISED HIV FUSION INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/015493 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11068 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048879.pdf [firstpage_image] =>[orig_patent_app_number] => 12015493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477611 [patent_doc_number] => 20100285061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'DNA VACCINATION PROTOCOLS' [patent_app_type] => utility [patent_app_number] => 12/522775 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32524 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285061.pdf [firstpage_image] =>[orig_patent_app_number] => 12522775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153458 [patent_doc_number] => 08586364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Cells and methodology to generate non-segmented negative-strand RNA viruses' [patent_app_type] => utility [patent_app_number] => 12/448468 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17293 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12448468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739906 [patent_doc_number] => 20080233559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein' [patent_app_type] => utility [patent_app_number] => 11/962315 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34204 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233559.pdf [firstpage_image] =>[orig_patent_app_number] => 11962315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845504 [patent_doc_number] => 20080181912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'IGF-1 AS FELINE VACCINE ADJUVANT, IN PARTICULAR AGAINST FELINE RETROVIRUSES' [patent_app_type] => utility [patent_app_number] => 11/963085 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9960 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181912.pdf [firstpage_image] =>[orig_patent_app_number] => 11963085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6437630 [patent_doc_number] => 20100144014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHOD FOR AMPLIFYING HCV IN AEDES MOSQUITOES' [patent_app_type] => utility [patent_app_number] => 12/448420 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3669 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144014.pdf [firstpage_image] =>[orig_patent_app_number] => 12448420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314423 [patent_doc_number] => 20100111989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'RSV F-PROTEIN AND ITS USE' [patent_app_type] => utility [patent_app_number] => 12/520321 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12938 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111989.pdf [firstpage_image] =>[orig_patent_app_number] => 12520321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6632902 [patent_doc_number] => 20100004553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Device for Eliminating Liquid Condensation in a Mouthpiece' [patent_app_type] => utility [patent_app_number] => 12/513880 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 592 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004553.pdf [firstpage_image] =>[orig_patent_app_number] => 12513880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126883 [patent_doc_number] => 08574831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance' [patent_app_type] => utility [patent_app_number] => 11/933747 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 14298 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11933747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368390 [patent_doc_number] => 20090305949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'GLYCOSYLATED SPECIFICITY EXCHANGER' [patent_app_type] => utility [patent_app_number] => 11/930860 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18752 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305949.pdf [firstpage_image] =>[orig_patent_app_number] => 11930860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336827 [patent_doc_number] => 20090053291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/927793 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6402 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053291.pdf [firstpage_image] =>[orig_patent_app_number] => 11927793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4892982 [patent_doc_number] => 20080102080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/927783 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6095 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102080.pdf [firstpage_image] =>[orig_patent_app_number] => 11927783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778757 [patent_doc_number] => 20080286755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Immunoglobin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same' [patent_app_type] => utility [patent_app_number] => 11/975848 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9213 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286755.pdf [firstpage_image] =>[orig_patent_app_number] => 11975848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 31784 [patent_doc_number] => 07790180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Immunogenic composition of a homogeneous live attenuated human rotavirus population' [patent_app_type] => utility [patent_app_number] => 11/875286 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 10606 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790180.pdf [firstpage_image] =>[orig_patent_app_number] => 11875286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159807 [patent_doc_number] => 20110159036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'MVA expressing modified HIV envelope, GAG, and POL genes' [patent_app_type] => utility [patent_app_number] => 11/975643 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 24828 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20110159036.pdf [firstpage_image] =>[orig_patent_app_number] => 11975643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6484865 [patent_doc_number] => 20100092940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Method and Device for Detecting Feline Immunodeficiency Virus' [patent_app_type] => utility [patent_app_number] => 11/874002 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9614 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092940.pdf [firstpage_image] =>[orig_patent_app_number] => 11874002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264863 [patent_doc_number] => 20090117548 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2009-05-07 [patent_title] => 'ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1 INFECTED PATIENTS' [patent_app_type] => utility [patent_app_number] => 11/872842 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13758 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0117/20090117548.pdf [firstpage_image] =>[orig_patent_app_number] => 11872842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264863 [patent_doc_number] => 20090117548 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2009-05-07 [patent_title] => 'ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1 INFECTED PATIENTS' [patent_app_type] => utility [patent_app_number] => 11/872842 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13758 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0117/20090117548.pdf [firstpage_image] =>[orig_patent_app_number] => 11872842 [rel_patent_id] =>[rel_patent_doc_number] =>)